Tatiana A. Bogush
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Comparative Analysis of Quantitative Indicators of Progesterone Receptor Protein and mRNA Expression in Tumor Cell Lines.
Journal: Bulletin of experimental biology and medicine
Published: June 12, 2024
Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: August 20, 2022
Molecular Diagnostics of the Involvement of Visually Normal Mucosa in the Malignancy Process in Urothelial Bladder Cancer
Journal: Molekuliarnaia biologiia
Published: February 17, 2022
The expression and clinical significance of ERβ/ERα in ovarian cancer: can we predict the effectiveness of platinum plus taxane therapy?
Journal: Irish journal of medical science
Published: October 06, 2021
Panel of Candidate Genes to Predict the Survival of Patients with Clear Cell Renal Cancer on the Basis of Gene Expression Regulated by HIF1α/HIF2α.
Journal: Bulletin of experimental biology and medicine
Published: August 27, 2021
A new approach to epithelial-mesenchymal transition diagnostics in epithelial tumors: double immunofluorescent staining and flow cytometry.
Journal: BioTechniques
Published: August 12, 2020
BRCA1 and Estrogen Receptor α Expression Regulation in Breast Cancer Cells
Journal: Molekuliarnaia biologiia
Published: November 09, 2018
Estrogen Receptors alpha and beta in Ovarian Cancer: Expression Level and Prognosis.
Journal: Doklady. Biochemistry and biophysics
Published: April 12, 2018
New Data on Molecular Targets of Tamoxifen Besides Estrogen Receptors, Their Clinical Significancy.
Journal: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]
Published: August 01, 2016
Flow cytometric analysis of the ERCC1, marker of DNA damage repair, in the tumor specimens embedded into paraffin blocks.
Journal: Doklady. Biochemistry and biophysics
Published: July 26, 2016
Digoxin is a selective modifier increasing platinum drug anticancer activity.
Journal: Doklady. Biochemistry and biophysics
Published: February 20, 2016
Last Updated: 09/26/2026